UCB Group Says Cimzia EU Clearance Only a Matter of Time

BRUSSELS, April 24 (Reuters) - Belgian pharmaceutical group UCB said on Thursday it had little doubt that its Cimzia drug would be cleared by European authorities to treat bowel disorder Crohn's disease.